Pacira BioSciences, Inc. made company filings with the SEC and an analyst raised the stock rating on August 18, 2026.
2 reports, 1 independent
Updated Aug 18
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Pacira BioSciences, Inc. made company filings with the SEC and an analyst raised the stock rating on August 18, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Sell
German badminton player
-
Royal Bank of Canada
financial institution in Canada
Related events
- Monolithic Power Systems filed disclosures with the SEC, listed on Nasdaq, and saw Royal Bank of Canada increase its stock stake.
- Ligand Pharmaceuticals filed a transaction with the SEC, while Royal Bank of Canada lifted its target price, and the stock is listed on Nasdaq.
- Royal Bank of Canada raised its position in Bright Minds Biosciences Inc., a company trading on the Nasdaq exchange.
- General Counsel of Arthur J. Gallagher & Co. sold company stock, while major banks issued rating and price target updates.
- Permian Basin Royalty Trust filed required disclosures with the SEC, while Royal Bank of Canada simultaneously increased its holdings.